Viewing Study NCT05274269


Ignite Creation Date: 2025-12-24 @ 10:58 PM
Ignite Modification Date: 2026-02-24 @ 12:14 AM
Study NCT ID: NCT05274269
Status: COMPLETED
Last Update Posted: 2024-08-01
First Post: 2022-03-01
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Evaluation of Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) in Cystic Fibrosis Subjects Without an F508del Mutation
Sponsor: Vertex Pharmaceuticals Incorporated
Organization: